Scott Fidel
Stock Analyst at Stephens & Co.
(1.85)
# 2,869
Out of 4,814 analysts
183
Total ratings
50%
Success rate
1.93%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Scott Fidel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARDT Ardent Health Partners | Reiterates: Overweight | $22 | $12.51 | +75.86% | 4 | Apr 1, 2025 | |
| ADUS Addus HomeCare | Reiterates: Overweight | $142 | $101.19 | +40.33% | 12 | Mar 12, 2025 | |
| PNTG The Pennant Group | Reiterates: Overweight | $38 | $26.22 | +44.93% | 18 | Mar 11, 2025 | |
| AMED Amedisys | Reiterates: Equal-Weight | $101 | $91.88 | +9.93% | 13 | Mar 4, 2025 | |
| UHS Universal Health Services | Maintains: Equal-Weight | $210 → $223 | $174.51 | +27.79% | 10 | Feb 28, 2025 | |
| ALHC Alignment Healthcare | Reiterates: Overweight | $17 | $19.43 | -12.51% | 5 | Jan 2, 2025 | |
| CNC Centene | Maintains: Equal-Weight | $75 → $73 | $60.68 | +20.30% | 9 | Dec 13, 2024 | |
| UNH UnitedHealth Group | Maintains: Overweight | $605 → $675 | $454.11 | +48.64% | 22 | Dec 5, 2024 | |
| PACS PACS Group | Maintains: Overweight | $48 → $31 | $9.24 | +235.68% | 4 | Nov 18, 2024 | |
| CI The Cigna Group | Reiterates: Overweight | $410 | $330.19 | +24.17% | 12 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $163 → $167 | $127.91 | +30.56% | 9 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $21 | $23.90 | -12.13% | 1 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $250 | $264.38 | -5.44% | 7 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $615 | $424.53 | +44.87% | 3 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $105 | $103.53 | +1.42% | 10 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $320 | $322.37 | -0.74% | 9 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $95 → $122 | $121.51 | +0.40% | 10 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $92 | $23.91 | +284.78% | 9 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $280 | $334.38 | -16.26% | 9 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $95 | $0.96 | +9,768.08% | 4 | Jun 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $2.25 → $1.5 | $4.59 | -67.28% | 3 | Nov 11, 2022 |
Ardent Health Partners
Apr 1, 2025
Reiterates: Overweight
Price Target: $22
Current: $12.51
Upside: +75.86%
Addus HomeCare
Mar 12, 2025
Reiterates: Overweight
Price Target: $142
Current: $101.19
Upside: +40.33%
The Pennant Group
Mar 11, 2025
Reiterates: Overweight
Price Target: $38
Current: $26.22
Upside: +44.93%
Amedisys
Mar 4, 2025
Reiterates: Equal-Weight
Price Target: $101
Current: $91.88
Upside: +9.93%
Universal Health Services
Feb 28, 2025
Maintains: Equal-Weight
Price Target: $210 → $223
Current: $174.51
Upside: +27.79%
Alignment Healthcare
Jan 2, 2025
Reiterates: Overweight
Price Target: $17
Current: $19.43
Upside: -12.51%
Centene
Dec 13, 2024
Maintains: Equal-Weight
Price Target: $75 → $73
Current: $60.68
Upside: +20.30%
UnitedHealth Group
Dec 5, 2024
Maintains: Overweight
Price Target: $605 → $675
Current: $454.11
Upside: +48.64%
PACS Group
Nov 18, 2024
Maintains: Overweight
Price Target: $48 → $31
Current: $9.24
Upside: +235.68%
The Cigna Group
Nov 1, 2024
Reiterates: Overweight
Price Target: $410
Current: $330.19
Upside: +24.17%
Oct 28, 2024
Maintains: Overweight
Price Target: $163 → $167
Current: $127.91
Upside: +30.56%
Oct 22, 2024
Initiates: Overweight
Price Target: $21
Current: $23.90
Upside: -12.13%
Oct 9, 2024
Reiterates: Equal-Weight
Price Target: $250
Current: $264.38
Upside: -5.44%
Sep 5, 2024
Reiterates: Overweight
Price Target: $615
Current: $424.53
Upside: +44.87%
Aug 6, 2024
Reiterates: Overweight
Price Target: $105
Current: $103.53
Upside: +1.42%
Jul 25, 2024
Reiterates: Equal-Weight
Price Target: $320
Current: $322.37
Upside: -0.74%
May 1, 2024
Maintains: Equal-Weight
Price Target: $95 → $122
Current: $121.51
Upside: +0.40%
Jan 5, 2024
Upgrades: Overweight
Price Target: $92
Current: $23.91
Upside: +284.78%
Nov 10, 2023
Reiterates: Overweight
Price Target: $280
Current: $334.38
Upside: -16.26%
Jun 27, 2023
Reiterates: Overweight
Price Target: $95
Current: $0.96
Upside: +9,768.08%
Nov 11, 2022
Maintains: Equal-Weight
Price Target: $2.25 → $1.5
Current: $4.59
Upside: -67.28%